Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE) - Related Studies

Docetaxel Based Chemotherapy Plus or Minus Induction Chemotherapy to Decrease Events in Head and Neck Cancer (DeCIDE)

This study is currently recruiting participants.

Study NCT00117572. Last updated on April 1, 2008. Information provided by University of Chicago

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Cancer of the Pharynx
		Cancer of the Larynx
		Cancer of the Nasal Cavity
		Paranasal Sinus Neoplasms
		Cancer of the Oral Cavity

2	Additional conditions recognized in this trial
		Head and Neck Neoplasms
		Laryngeal Neoplasms
		Pharyngeal Neoplasms

3	More general conditions related to this trial
		Laryngeal Diseases
		Neoplasms
		Neoplasms by Site
		Nose Diseases
		Nose Neoplasms
		Otorhinolaryngologic Diseases
		Otorhinolaryngologic Neoplasms
		Paranasal Sinus Diseases
		Pharyngeal Diseases
		Respiratory Tract Diseases
		Respiratory Tract Neoplasms
		Stomatognathic Diseases

4	Interventions listed in this trial
		docetaxel
		cisplatin
		hydroxyurea
		fluorouracil
		chemotherapy
		radiotherapy

5	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antisickling Agents
		Enzyme Inhibitors
		Hematologic Agents
		Immunologic Factors
		Immunosuppressive Agents
		Molecular Mechanisms of Pharmacological Action
		Nucleic Acid Synthesis Inhibitors
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses

6	Sponsors listed in this trial
		University of Chicago